Christian Sandrock, MD, MPH, FCCP, discusses the barriers to establish a successful protocol for outpatient parenteral antibiotic therapy in hospital systems where one does not currently exist, and provides an outlook on the future of long-acting lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections.
Mike Ison, MD, MS, discusses the key takeaways from the CAPSTONE-2 phase 3 trial evaluating baloxavir marboxil for the treatment of patients with influenza.
As clinicians and health care executives work to strike a balance between reducing costs and improving clinical outcomes, the importance of sepsis identification and treatment cannot be underscored enough, and starts with evaluating current practices for
Some people living with HIV who have undergone stem-cell transplants have seen a radical reduction in their HIV reservoir. A new study examines the factors that may be behind this phenomenon.
